Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT07784881Completed
Deciphering the Self-antigen Specific T Cell Signature of Autoimmune Liver Diseases
Autoimmune HepatitisAutoimmune Liver DiseasePrimary Biliary Cholangitis (PBC)+1 more
PrincipalinvestigatorStart date: 2021-04-20

Research Network

Collaboration Network

14 collaborators·58 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Didier SAMUEL

Hôpital Paul Brousse

Related
1 trials

Shared therapeutic areas:

Chronic HCV Infection

Worked with same sponsors:

Merck Sharp & Dohme LLCUniversity Hospital, Clermont-Ferrand
Collaborated on 1 trial
Similarity Score14%

Véronique LOUSTAUD RATTI

CHU LIMOGES

Related
1 trials

Shared therapeutic areas:

Chronic HCV Infection

Worked with same sponsors:

Merck Sharp & Dohme LLCUniversity Hospital, Clermont-Ferrand
Collaborated on 1 trial
Similarity Score14%

Christophe HEZODE

CHU Henri Mondor

Related
1 trials

Shared therapeutic areas:

Chronic HCV Infection

Worked with same sponsors:

Merck Sharp & Dohme LLCUniversity Hospital, Clermont-Ferrand
Collaborated on 1 trial
Similarity Score14%

Valérie CANVA

CHU de Lille

Related
1 trials

Shared therapeutic areas:

Chronic HCV Infection

Worked with same sponsors:

Merck Sharp & Dohme LLCUniversity Hospital, Clermont-Ferrand
Collaborated on 1 trial
Similarity Score14%

François BAILLY

Hospice civils de Lyon, hopital de la croix Rousse

Related
1 trials

Shared therapeutic areas:

Chronic HCV Infection

Worked with same sponsors:

Merck Sharp & Dohme LLCUniversity Hospital, Clermont-Ferrand
Collaborated on 1 trial
Similarity Score14%

Dominique LARREY

University Hospital, Montpellier

Related
1 trials

Shared therapeutic areas:

Chronic HCV Infection

Worked with same sponsors:

Merck Sharp & Dohme LLCUniversity Hospital, Clermont-Ferrand
Collaborated on 1 trial
Similarity Score14%

Isabelle FOUCHART-HUBERT

University Hospital, Angers

Related
1 trials

Shared therapeutic areas:

Chronic HCV Infection

Worked with same sponsors:

Merck Sharp & Dohme LLCUniversity Hospital, Clermont-Ferrand
Collaborated on 1 trial
Similarity Score14%

Armand ABERGEL

University Hospital, Clermont-Ferrand

Related
2 trials

Shared therapeutic areas:

Chronic HCV Infection

Worked with same sponsors:

Merck Sharp & Dohme LLCUniversity Hospital, Clermont-Ferrand
Collaborated on 1 trial
Similarity Score14%

Sophie METIVIER

CHU Toulouse Hopital Purpan

Related
1 trials

Shared therapeutic areas:

Chronic HCV Infection

Worked with same sponsors:

Merck Sharp & Dohme LLCUniversity Hospital, Clermont-Ferrand
Collaborated on 1 trial
Similarity Score14%

Stanislas POL

AP-HP Hopital Cochin

Related
1 trials

Shared therapeutic areas:

Chronic HCV Infection

Worked with same sponsors:

Merck Sharp & Dohme LLCUniversity Hospital, Clermont-Ferrand
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT07784881PrincipalInvestigator

Deciphering the Self-antigen Specific T Cell Signature of Autoimmune Liver Diseases

Autoimmune HepatitisAutoimmune Liver DiseasePrimary Biliary Cholangitis (PBC)+1 more
Completed
NCT02973503Phase 3PrincipalInvestigator

Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, With Non-severe Fibrosis

Chronic HCV Infection
Completed

All 2 trials loaded